Andrew Leavitt
Institution Name:
University of California, San Francisco
Total Awards:
2
Award Value:
$3,877,422
Awards as PI
Program Type | Institution | Grant Title | Award Value |
---|---|---|---|
Comprehensive Grant | University of California, San Francisco | Understanding hESC-based Hematopoiesis for Therapeutic Benefit | $2,460,822 |
Tools and Technologies III | University of California, San Francisco | Small molecule tools and scale-up technologies to expand human umbilical cord blood stem and progenitor cells for clinical and research use | $1,416,600 |
Total: $3,877,422.00 |
Publications
- Stem Cells Dev 2009 Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures. (PubMed: 19254177)
- Clin Transl Sci 2011 Homologous recombination in human embryonic stem cells: a tool for advancing cell therapy and understanding and treating human disease. (PubMed: 21884519)